At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Clinical Trial Assessing Continuous HAART Versus Interrupted HAART in a Resource Poor Clinic
In Brief
A clinical study evaluating Structured treatment interruption, Lamivudine, and 3 other interventions for HIV Infections. Completed, enrolled 30 participants across 1 site.
Detailed Summary
HIV infected people often must take anti-HIV drugs for long periods, leading to long-term drug exposure and toxicity. Interruptions in anti-HIV therapy, also known as structured treatment interruptions (STIs), may have few negative health effects and may be helpful to the overall long-term health of HIV-infected people. The purpose of this study is to determine if sequential short-term STIs of antiretroviral therapy (ART) in HIV infected individuals in a resource-constrained environment can retain the immune reconstitution benefits of continuous treatment while potentially lessening rates of toxicity associated with continuous therapy strategies and at the same time, lessen costs associated with ART.
Study Details
Timeline
Interventions
Interruptions in treatment will last 2, 4, and 8 weeks in between 16-week periods of ART
300 mg tablet taken orally daily
400 mg lopinavir/100 mg ritonavir tablet taken orally twice daily
Dosage dependent on weight
Vaccine injected intramuscularly